The China Mail - US researchers seek to legitimize AI mental health care

USD -
AED 3.672992
AFN 69.489986
ALL 84.291688
AMD 383.839605
ANG 1.789699
AOA 916.999967
ARS 1319.896786
AUD 1.54696
AWG 1.8025
AZN 1.703586
BAM 1.695528
BBD 2.019931
BDT 122.652264
BGN 1.702503
BHD 0.376963
BIF 2942.5
BMD 1
BND 1.289721
BOB 6.912904
BRL 5.607501
BSD 1.000429
BTN 87.444679
BWP 13.523249
BYN 3.273935
BYR 19600
BZD 2.009545
CAD 1.380165
CDF 2889.999809
CHF 0.809365
CLF 0.024626
CLP 965.903248
CNY 7.176898
CNH 7.203695
COP 4180.22
CRC 505.767255
CUC 1
CUP 26.5
CVE 95.950068
CZK 21.408976
DJF 177.720257
DKK 6.494535
DOP 61.000234
DZD 130.665077
EGP 48.688802
ERN 15
ETB 138.195699
EUR 0.870199
FJD 2.26455
FKP 0.749719
GBP 0.75184
GEL 2.683085
GGP 0.749719
GHS 10.501353
GIP 0.749719
GMD 72.000309
GNF 8655.999991
GTQ 7.675736
GYD 209.303031
HKD 7.84994
HNL 26.350282
HRK 6.563398
HTG 131.278148
HUF 348.138498
IDR 16447.4
ILS 3.370915
IMP 0.749719
INR 87.524998
IQD 1310
IRR 42112.496152
ISK 123.77952
JEP 0.749719
JMD 160.078717
JOD 0.709016
JPY 148.737499
KES 129.502337
KGS 87.449649
KHR 4015.000089
KMF 426.481732
KPW 899.916557
KRW 1389.709963
KWD 0.305703
KYD 0.833727
KZT 543.834174
LAK 21574.999791
LBP 89550.000023
LKR 302.24403
LRD 200.999765
LSL 17.890173
LTL 2.95274
LVL 0.60489
LYD 5.414999
MAD 9.089499
MDL 17.067261
MGA 4430.000077
MKD 53.368936
MMK 2098.902778
MNT 3590.484358
MOP 8.089174
MRU 39.820637
MUR 46.119586
MVR 15.401776
MWK 1736.499952
MXN 18.77485
MYR 4.240579
MZN 63.959915
NAD 17.889939
NGN 1531.000199
NIO 36.750139
NOK 10.251295
NPR 139.9101
NZD 1.687835
OMR 0.384529
PAB 1.000438
PEN 3.552498
PGK 4.152023
PHP 57.854002
PKR 283.249583
PLN 3.71645
PYG 7492.815376
QAR 3.64075
RON 4.416704
RSD 102.004735
RUB 81.252889
RWF 1440
SAR 3.75154
SBD 8.244163
SCR 14.472936
SDG 600.502571
SEK 9.71061
SGD 1.292885
SHP 0.785843
SLE 23.000277
SLL 20969.503947
SOS 571.50088
SRD 36.670024
STD 20697.981008
STN 21.45
SVC 8.753321
SYP 13001.94935
SZL 17.889582
THB 32.651497
TJS 9.563891
TMT 3.51
TND 2.894989
TOP 2.342098
TRY 40.582505
TTD 6.788933
TWD 29.70101
TZS 2570.000105
UAH 41.765937
UGX 3586.538128
UYU 40.034504
UZS 12600.000148
VES 122.68725
VND 26202.5
VUV 119.475888
WST 2.757115
XAF 568.669132
XAG 0.026577
XAU 0.000303
XCD 2.70255
XCG 1.80294
XDR 0.69341
XOF 568.664202
XPF 103.850093
YER 240.649912
ZAR 17.932005
ZMK 9001.198585
ZMW 22.984061
ZWL 321.999592
  • RBGPF

    -3.5200

    74.03

    -4.75%

  • BCC

    -1.2500

    84.89

    -1.47%

  • CMSC

    -0.0100

    22.6

    -0.04%

  • VOD

    -0.0500

    11.06

    -0.45%

  • SCS

    -0.1800

    10.33

    -1.74%

  • BCE

    -0.1300

    23.53

    -0.55%

  • NGG

    -0.3300

    70.19

    -0.47%

  • SCU

    0.0000

    12.72

    0%

  • RELX

    -0.1400

    51.78

    -0.27%

  • RYCEF

    -0.2800

    13.1

    -2.14%

  • JRI

    0.0500

    13.11

    +0.38%

  • RIO

    -2.7800

    59.49

    -4.67%

  • GSK

    1.3000

    38.97

    +3.34%

  • CMSD

    -0.0600

    23.06

    -0.26%

  • AZN

    2.6100

    76.59

    +3.41%

  • BTI

    0.3900

    53.16

    +0.73%

  • BP

    -0.7100

    32.25

    -2.2%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

K.Lam--ThChM